Drug profile · INN
iotrolan
OSMOVIST 240
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
iotrolan (OSMOVIST 240) is an FDA-listed pharmaceutical active ingredient. Route of administration: intrathecal. Current US regulatory status: approved.
Key facts
INN iotrolan
Brand OSMOVIST 240
Route INTRATHECAL
Formulation INJECTABLE
Frequently asked questions
What is iotrolan?
iotrolan (OSMOVIST 240) is an FDA-listed pharmaceutical active ingredient. Route of administration: intrathecal. Current US regulatory status: approved.
What is the brand name for iotrolan?
OSMOVIST 240 is a marketed brand name for iotrolan. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of iotrolan?
iotrolan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.